Diadembio
1 known investors
Diadem Biotherapeutics develops immunotherapies using its DECOSTAR platform of decorated extracellular vesicles designed to activate or repress costimulatory immune receptors. The company targets diseases by tuning immune cell function through agonist signaling.
BiotechHealthtech
Investors Β· 1
Frequently asked questions
- What does Diadembio do?
- Diadem Biotherapeutics develops immunotherapies using its DECOSTAR platform of decorated extracellular vesicles designed to activate or repress costimulatory immune receptors. The company targets diseases by tuning immune cell function through agonist signaling.
- Who are Diadembio's investors?
- Diadembio's investors include Beresford Ventures.